Arcutis Biotherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Arcutis Biotherapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1517% to $59,606,000. The net income raised on -$262,140,000 and profit margin reached -440%. Total operating expenses were $295,720,000.
Profit Margin
| 2017 | 0 | -4.97M | |
|---|---|---|---|
| 2018 | 0 | -19.25M | |
| 2019 | 0 | -41.99M | |
| 2020 | 0 | -135.67M | |
| 2021 | 0 | -205.90M | |
| 2022 | 3.68M | -321.28M | -8716.47% |
| 2023 | 59.60M | -262.14M | -439.79% |
ARQT Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 59.60M | 3.68M | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 4.98M | 754K | 763K | 455K | 195K | 0 | 0 |
Gross profit | 54.61M | 2.93M | -763K | -455K | -195K | 0 | 0 |
Operating exp. | |||||||
Research and development | 110.57M | 182.43M | 145.55M | 115.30M | 36.52M | 17.94M | 3.41M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 295.72M | 304.55M | 206.52M | 136.64M | 43.13M | 19.73M | 4.10M |
Operating income | -241.10M | -301.62M | -206.52M | -136.64M | -43.13M | -19.73M | -4.10M |
Other income (expenses), net | -17.92M | -9.83M | 173K | 967K | 1.13M | 480K | -872K |
Income before tax | -259.02M | -311.45M | -206.35M | -135.67M | -41.99M | -19.25M | -4.97M |
Income tax expense | 3.11M | 9.83M | -454K | -84.29K | 0 | -480K | -4.10M |
Net income | -262.14M | -321.28M | -205.90M | -135.67M | -41.99M | -19.25M | -4.97M |
Earnings per share | |||||||
Basic EPS | -3.78 | -5.84 | -4.17 | -3.8 | -1.1 | -1.07 | -0.13 |
Diluted EPS | -3.78 | -5.84 | -4.17 | -3.8 | -1.1 | -1.07 | -0.13 |
| Data source | Data source | Data source | Data source | Data source |